HALLIE RUBIN: Open Payments
NPI 1528622891 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,986 in 107 payments from 19 companies in 2025. Trend: 2023 $984 · 2024 $2,119 · 2025 $1,986
Food & beverage: $1,986
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $244 |
| Otsuka America Pharmaceutical, Inc. | 13 | $229 |
| Janssen Pharmaceuticals, Inc | 9 | $202 |
| ABBVIE INC. | 12 | $181 |
| Supernus Pharmaceuticals, Inc. | 7 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $148 |
| Lundbeck LLC | 6 | $114 |
| Collegium Pharmaceutical, Inc. | 5 | $95 |
| Bausch Health US, LLC | 5 | $90 |
Products named: REXULTI, ARISTADA, VRAYLAR, Qelbree, CAPLYTA, TRINTELLIX, SPRAVATO, Jornay PM.
Industry payments across GA — which companies pay providers there.
